Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
PolandStudy on Metformin's Effect in Reducing Unplanned Heart Procedures in Non-Diabetic Patients with Acute Coronary Syndrome
PolandStudy on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency
PolandStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
PolandStudy of Elafibranor for Adults with Primary Biliary Cholangitis
PolandLong-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine
PolandStudy on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
PolandStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
PolandStudy on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals
PolandStudy on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions
PolandStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
PolandStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
